ERBB2 and non-small cell lung carcinoma: Currently, a family of Ex20ins has been described in the human epidermal growth factor receptor 2 gene (HER2, also known as ERBB2), which consists of 90% of HER2 alterations in NSCLC, and approximately 2%–4% of patients with NSCLC harbor these mutations.11, 12